Multi-institutional survey of thymic carcinoma patients in Hokushin region
- PMID: 33963906
- PMCID: PMC11801157
- DOI: 10.1007/s00432-021-03620-8
Multi-institutional survey of thymic carcinoma patients in Hokushin region
Abstract
Background: Thymic carcinoma is a rare neoplasm, and its prognosis is very poor. The purpose of this study was to validate the clinical and epidemiological factors, diagnosis and initial treatment of thymic carcinoma among all patients diagnosed in the registered hospital group.
Methods: We surveyed retrospective data from 152,921 cancer patients in 22 principal hospitals.
Results: A total of 88 thymic carcinoma cases were newly diagnosed. These patients were 50 men and 38 women, with a median age of 66 years old. Eight patients were discovered in cancer screening, 9 in a voluntary setting, 14 at health checkups, 25 at follow-up of other diseases, and 32 cases by introduction from another hospital. Only 14 cases had been diagnosed with localized disease, but 5 cases were accompanied by regional lymph node metastasis. Furthermore, 12 cases showed infiltration into adjacent organs, and 24 cases had distant metastasis. Eighty-three cases were diagnosed by a pathological diagnosis. A surgical approach, chemotherapy, and radiotherapy were performed for 29, 35 patients, and 31 patients, respectively, while 17 patients received best supportive care.
Conclusion: The diagnosis of thymic carcinoma is still difficult, and this disease has a tragically rapid progression if when discovered during follow-up of other diseases. An innovative modality for the early detection of thymic carcinoma is needed in modern medical society.
Keywords: Cancer registration; Cancer screening; Ganpro database; Hokushin region; Thymic carcinoma.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
TK received honoraria for AstraZeneca Co. LTD, and Ono Pharmaceutical Co., LTD. MN received honoraria for DAIICHI SANKYO COMPANY and Eisai Japan Co and received a research Grant from Eisai Japan Co. All other authors declared no conflict of interest.
Figures





Similar articles
-
Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region.J Cancer Res Clin Oncol. 2022 May;148(5):1153-1158. doi: 10.1007/s00432-021-03699-z. Epub 2021 Jun 29. J Cancer Res Clin Oncol. 2022. PMID: 34185142 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
Cited by
-
Epidemiological and therapeutic profiles of lung cancer patients in the Hokushin Region Japan: a retrospective hospital administrative database study.BMC Pulm Med. 2023 Sep 1;23(1):322. doi: 10.1186/s12890-023-02610-5. BMC Pulm Med. 2023. PMID: 37658334 Free PMC article.
-
Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region.J Cancer Res Clin Oncol. 2022 May;148(5):1153-1158. doi: 10.1007/s00432-021-03699-z. Epub 2021 Jun 29. J Cancer Res Clin Oncol. 2022. PMID: 34185142 Free PMC article.
-
Multi-institutional survey of antiemetic therapy in lung cancer patients treated with carboplatin in Hokushin region.BMC Pulm Med. 2023 Jun 26;23(1):228. doi: 10.1186/s12890-023-02524-2. BMC Pulm Med. 2023. PMID: 37365528 Free PMC article.
-
Genomic insights into molecular profiling of thymic carcinoma: a narrative review.Mediastinum. 2024 Jun 5;8:39. doi: 10.21037/med-24-5. eCollection 2024. Mediastinum. 2024. PMID: 39161584 Free PMC article. Review.
References
-
- Engels EA, Pfeiffer RM (2003) Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105:546–551 - PubMed
-
- Filosso PL, Yao X, Ruffini E, Ahmad U, Antonicelli A, Huang J et al (2016) Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group. Eur J Cardiothorac Surg 50:766–771 - PMC - PubMed
-
- Higashi T, Nakamura F, Shibata A, Emori Y, Nishimoto H (2014) The national database of hospital-based cancer registries: a nationwide infrastructure to support evidence-based cancer care and cancer control policy in Japan. Jpn J Clin Oncol 44:2–8 - PubMed
-
- Hishida T, Nomura S, Yano M, Asamura H, Yamashita M, Ohde Y, Japanese Association for Research on the Thymus (JART) et al (2016) Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg 49:835–841 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical